Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's Intraday Session

 

Gainers

  • BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8% of BiondVax Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $31.9 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares increased by 25.67% to $6.59. As of 13:31 EST, this security is trading at a volume of 4.5 million shares, making up 3232.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $32.9 million. As per the news, the Q4 earnings report came out today.
  • Mustang Bio (NASDAQ:MBIO) stock rose 23.65% to $1.15. As of 13:31 EST, Mustang Bio's stock is trading at a volume of 2.5 million, which is 260.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $107.4 million. As per the press release, Q4 earnings came out yesterday.
  • Gracell Biotechnologies (NASDAQ:GRCL) stock increased by 19.02% to $2.69. Gracell Biotechnologies's stock is trading at a volume of 1.5 million shares as of 13:31 EST. This is 580.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $181.5 million.
  • Zosano Pharma (NASDAQ:ZSAN) stock rose 16.38% to $0.27. As of 13:31 EST, Zosano Pharma's stock is trading at a volume of 65.5 million, which is 611.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $46.2 million.
  • Evelo Biosciences (NASDAQ:EVLO) stock rose 16.05% to $3.79. As of 13:31 EST, Evelo Biosciences's stock is trading at a volume of 452.6K, which is 145.4% of its average full-day volume over the last 100 days. The company's market cap stands at $202.8 million. The company's, Q4 earnings came out today.

 

Losers

  • Diffusion Pharmaceuticals (NASDAQ:DFFN) stock declined by 15.9% to $0.28 during Thursday's regular session. As of 13:31 EST, Diffusion Pharmaceuticals's stock is trading at a volume of 2.5 million, which is 251.8% of its average full-day volume over the last 100 days. The company's market cap stands at $29.0 million. As per the press release, Q4 earnings came out 4 days ago.
  • Sonendo (NYSE:SONX) stock fell 14.97% to $4.66. Trading volume for Sonendo's stock is 92.9K as of 13:31 EST. This is 75.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $122.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Aptinyx (NASDAQ:APTX) stock fell 11.53% to $2.61. The current volume of 200.0K shares is 129.4% of Aptinyx's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $176.7 million. As per the press release, Q4 earnings came out yesterday.
  • LumiraDx (NASDAQ:LMDX) shares fell 11.32% to $7.92. The market value of their outstanding shares is at $2.0 billion.
  • Precipio (NASDAQ:PRPO) stock declined by 10.95% to $1.22. Precipio's stock is trading at a volume of 373.4K shares as of 13:31 EST. This is 217.8% of its average full-day volume over the last 100 days. The company's market cap stands at $27.7 million.
  • Stealth BioTherapeutics (NASDAQ:MITO) stock fell 10.94% to $0.63. Trading volume for Stealth BioTherapeutics's stock is 504.1K as of 13:31 EST. This is 260.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.